Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001765427 | SCV001998101 | likely pathogenic | not provided | 2023-06-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34163037) |
Mendelics | RCV002246476 | SCV002518629 | pathogenic | Timothy syndrome | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003647853 | SCV004489946 | pathogenic | Long QT syndrome | 2023-12-19 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 1167 of the CACNA1C protein (p.Val1167Ala). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Clinical features of Timothy syndrome (PMID: 34163037). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 1309258). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CACNA1C protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |